Results 1 to 10 of about 194,896 (346)

Human parainfluenza 3 and respiratory syncytial viruses detected in pangolins [PDF]

Emerging Microbes and Infections, 2022
Pangolins have gained increasing global attention owing to their public health significance as potential zoonotic hosts since the identification of SARS-CoV-2-related viruses in them. Moreover, these animals could carry other respiratory viruses. In this
Tengcheng Que, Jing Li, Yugan He, Panyu Chen, Wei Lin, Meihong He, Lei Yu, Aiqiong Wu, Luohao Tan, Yingjiao Li, Yanling Hu, Yigang Tong   +11 more
doaj   +4 more sources

Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial Viruses. [PDF]

Antimicrob Agents Chemother, 2018
Morbidity and mortality resulting from influenza-like disease are a threat, especially for older adults. To improve case management, next-generation broad-spectrum antiviral therapeutics that are efficacious against major drivers of influenza-like ...
Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, Ganti K, Cox RM, Sticher ZM, Edpuganti V, Mitchell DG, Lockwood MA, Kolykhalov AA, Greninger AL, Moore ML, Painter GR, Lowen AC, Tompkins SM, Fearns R, Natchus MG, Plemper RK.   +20 more
europepmc   +2 more sources

1409. Genomic Variation Among Respiratory Syncytial Viruses [PDF]

Open Forum Infect Dis, 2020
Abstract Background Respiratory Syncytial Virus (RSV) can be easily classified into two subtypes (A and B) based on the nucleic acid sequence of their genome. Phylogenic approaches have shown that within both subtypes separate lineages of viruses exist and new lineages continue to emerge.
Anderson C, Zhang Y, Corbett A, Chu C, Wang L, Qiu X, McCall M, Topham D, Mariani T, Walsh E, Scheuermann R, Caserta M.   +11 more
europepmc   +3 more sources

Bivalent vaccines effectively protect mice against influenza A and respiratory syncytial viruses. [PDF]

Emerg Microbes Infect, 2023
Influenza and Respiratory Syncytial virus (RSV) infections together contribute significantly to the burden of acute lower respiratory tract infections. Despite the disease burden, no approved RSV vaccine is available. While approved vaccines are available for influenza, seasonal vaccination is required to maintain protection.
Raman SNT, Zetner A, Hashem AM, Patel D, Wu J, Gravel C, Gao J, Zhang W, Pfeifle A, Tamming L, Parikh K, Cao J, Tam R, Safronetz D, Chen W, Johnston MJW, Wang L, Sauve S, Rosu-Myles M, Domselaar GV, Li X.   +20 more
europepmc   +5 more sources

In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab [PDF]

Journal of Virology, 2005
ABSTRACT Palivizumab (PZ) is the only monoclonal antibody currently available for use in humans against an infectious disease. PZ is administered prophylactically for respiratory syncytial virus (RSV) infections. RSV selected in cell culture for growth in the presence of PZ develops F gene mutations and can be resistant to PZ prophylaxis in ...
Xiaodong, Zhao, Wayne M, Sullender
openaire   +3 more sources

Multiplex PCR for Typing and Subtyping Influenza and Respiratory Syncytial Viruses [PDF]

Journal of Clinical Microbiology, 1998
ABSTRACT A multiplex reverse transcription (RT)-PCR method that has been developed is capable of detecting and subtyping influenza A (H1N1 and H3N2) and B viruses as well as respiratory syncytial virus (RSV) types A and B in respiratory clinical samples taken as part of a national community-based surveillance program of influenza-like illness
J, Stockton, J S, Ellis, M, Saville, J P, Clewley, M C, Zambon   +4 more
openaire   +3 more sources

Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses [PDF]

Journal of Virology, 1991
Respiratory syncytial (RS) virus causes repeated infections throughout life. Between the two main antigenic subgroups of RS virus, there is antigenic variation in the attachment protein G. The antigenic differences between the subgroups appear to play a role in allowing repeated infections to occur.
W M, Sullender, M A, Mufson, L J, Anderson, G W, Wertz   +3 more
openaire   +3 more sources

Respiratory syncytial virus in hematopoietic cell transplant recipients and patients with hematologic malignancies

Haematologica, 2019
In the USA and other western nations, respiratory syncytial virus is one of the most commonly encountered respiratory viruses among patients who have been diagnosed with a hematologic malignancy or who have undergone a stem cell transplant.
Fareed Khawaja, Roy F. Chemaly
doaj   +2 more sources

Evolutionary trends of respiratory syncytial viruses: Insights from large-scale surveillance and molecular dynamics of G glycoprotein. [PDF]

Heliyon
Amjad MN, Wang J, Ashraf MA, Shen B, Din GU, Raza MA, Shoaib M, Yue L, Chen L, Xu H, Dong W, Hu Y.   +11 more
europepmc   +3 more sources

Lack of association between viral load and severity of acute bronchiolitis in infants [PDF]

Jornal Brasileiro de Pneumologia, 2016
Objective: To investigate the correlation between respiratory syncytial viral load and length of hospitalization in infants with acute wheezing episodes.
Ana Paula Duarte de Souza, Lidiane Alves de Azeredo Leitão, Fernanda Luisi, Rodrigo Godinho Souza, Sandra Eugênia Coutinho, Jaqueline Ramos da Silva, Rita Mattiello, Paulo Márcio Condessa Pitrez, Renato Tetelbom Stein, Leonardo Araújo Pinto   +9 more
doaj   +6 more sources